Net Cash Provided by (Used in) Operating Activities in USD of REGENERON PHARMACEUTICALS, INC. from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
REGENERON PHARMACEUTICALS, INC. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from Q1 2010 to Q1 2025.
  • REGENERON PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $1.05B, a 30.9% decline year-over-year.
  • REGENERON PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $4.42B, a 3.78% decline from 2023.
  • REGENERON PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $4.59B, a 8.39% decline from 2022.
  • REGENERON PHARMACEUTICALS, INC. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $5.01B, a 29.2% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

REGENERON PHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $1.05B -$467M -30.9% 01 Jan 2025 31 Mar 2025 10-Q 29 Apr 2025
Q1 2024 $1.51B +$145M +10.6% 01 Jan 2024 31 Mar 2024 10-Q 29 Apr 2025
Q1 2023 $1.37B -$734M -34.9% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024
Q1 2022 $2.1B +$1.43B +214% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q1 2021 $669M -$29.5M -4.23% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022
Q1 2020 $698M -$199M -22.2% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021
Q1 2019 $897M +$278M +45% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020
Q1 2018 $619M +$263M +73.9% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019
Q1 2017 $356M +$311M +691% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018
Q1 2016 $45M +$147M 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017
Q1 2015 -$102M -$155M -290% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016
Q1 2014 $53.5M -$32.7M -37.9% 01 Jan 2014 31 Mar 2014 10-Q 07 May 2015
Q1 2013 $86.2M +$173M 01 Jan 2013 31 Mar 2013 10-Q 08 May 2014
Q1 2012 -$87M -$76.5M -723% 01 Jan 2012 31 Mar 2012 10-Q 03 May 2013
Q1 2011 -$10.6M -$1M -10.5% 01 Jan 2011 31 Mar 2011 10-Q 26 Apr 2012
Q1 2010 -$9.58M 01 Jan 2010 31 Mar 2010 10-Q 03 May 2011

REGENERON PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.42B -$174M -3.78% 01 Jan 2024 31 Dec 2024 10-K 05 Feb 2025
2023 $4.59B -$421M -8.39% 01 Jan 2023 31 Dec 2023 10-K 05 Feb 2025
2022 $5.01B -$2.07B -29.2% 01 Jan 2022 31 Dec 2022 10-K 05 Feb 2025
2021 $7.08B +$4.46B +170% 01 Jan 2021 31 Dec 2021 10-K 05 Feb 2024
2020 $2.62B +$188M +7.74% 01 Jan 2020 31 Dec 2020 10-K 06 Feb 2023
2019 $2.43B +$235M +10.7% 01 Jan 2019 31 Dec 2019 10-K 07 Feb 2022
2018 $2.2B +$888M +67.9% 01 Jan 2018 31 Dec 2018 10-K 08 Feb 2021
2017 $1.31B -$179M -12% 01 Jan 2017 31 Dec 2017 10-K 07 Feb 2020
2016 $1.49B +$155M +11.7% 01 Jan 2016 31 Dec 2016 10-K 07 Feb 2019
2015 $1.33B +$578M +76.9% 01 Jan 2015 31 Dec 2015 10-K 08 Feb 2018
2014 $752M +$164M +27.8% 01 Jan 2014 31 Dec 2014 10-K 09 Feb 2017
2013 $589M +$663M 01 Jan 2013 31 Dec 2013 10-K 11 Feb 2016
2012 -$74.6M +$67.1M +47.3% 01 Jan 2012 31 Dec 2012 10-K 12 Feb 2015
2011 -$142M -$241M -243% 01 Jan 2011 31 Dec 2011 10-K 13 Feb 2014
2010 $99.2M 01 Jan 2010 31 Dec 2010 10-K 15 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.